Year To Quarter End Consolidated Statement Of Comprehensive Income

OncoTherapy Science, Inc. - Filing #7300533

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-545,699,000 JPY
-710,663,000 JPY
Comprehensive income
-545,699,000 JPY
-710,663,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-545,699,000 JPY
-710,663,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.